Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

2
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
2
Obesity01:24

Obesity

1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

9
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
9
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.7K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

2
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
2
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

4.8K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal and cross-sectional evidence that daily resting and activity energy expenditures are independent in humans.

The Journal of physiology·2026
Same author

Self-selected dietary intake and association with achieved caloric restriction in CALERIE<sup>™</sup> 2.

Critical reviews in food science and nutrition·2026
Same author

The impact of maternal metabolic flexibility during gestation on infant adiposity in individuals with obesity.

American journal of physiology. Endocrinology and metabolism·2026
Same author

Skeletal muscle mitochondrial bioenergetics in pregnancy: a comparison of in vivo and in vitro outcomes.

Journal of the Endocrine Society·2026
Same author

Disseminating and Implementing the Science of Pediatric Obesity Treatment and Prevention.

Obesity (Silver Spring, Md.)·2026
Same author

Metabolic Adaptations to Caloric Restriction: Time- and Group-Dependent Metabolomic Signatures from the CALERIE<sup>™</sup> Trial.

Research square·2026

Related Experiment Video

Updated: Apr 20, 2026

Localization, Identification, and Excision of Murine Adipose Depots
08:53

Localization, Identification, and Excision of Murine Adipose Depots

Published on: December 4, 2014

42.4K

Adipose tissue inflammation and metabolic dysfunction: a clinical perspective.

Charmaine S Tam1, Leanne M Redman

  • 1The Charles Perkins Centre, School of Biological Sciences, Sydney Medical School, The University of Sydney, Australia.

Hormone Molecular Biology and Clinical Investigation
|December 2, 2014
PubMed
Summary

Obesity causes chronic inflammation in adipose tissue, increasing insulin resistance and type 2 diabetes risk. This review explores how adipose tissue inflammation impacts obesity complications in humans.

More Related Videos

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

26.1K
Exploring Adipose Tissue Structure by Methylsalicylate Clearing and 3D Imaging
10:10

Exploring Adipose Tissue Structure by Methylsalicylate Clearing and 3D Imaging

Published on: August 19, 2020

8.4K

Related Experiment Videos

Last Updated: Apr 20, 2026

Localization, Identification, and Excision of Murine Adipose Depots
08:53

Localization, Identification, and Excision of Murine Adipose Depots

Published on: December 4, 2014

42.4K
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

26.1K
Exploring Adipose Tissue Structure by Methylsalicylate Clearing and 3D Imaging
10:10

Exploring Adipose Tissue Structure by Methylsalicylate Clearing and 3D Imaging

Published on: August 19, 2020

8.4K

Area of Science:

  • Immunology
  • Metabolic Disorders
  • Endocrinology

Background:

  • Obesity is linked to chronic low-grade inflammation driven by immune cells, particularly macrophages, in adipose tissue.
  • This adipose tissue inflammation releases proinflammatory mediators, leading to systemic effects.
  • Such inflammation can disrupt insulin signaling, elevating the risk of insulin resistance and type 2 diabetes.

Purpose of the Study:

  • To review clinical studies on adipose tissue's role in obesity-associated complications.
  • To update on human studies investigating adipose tissue inflammation in various metabolic states.

Main Methods:

  • Literature review of clinical studies.
  • Analysis of research on energy imbalance and metabolic dysfunction.
  • Examination of studies related to weight loss interventions and insulin resistance conditions.

Main Results:

  • Adipose tissue inflammation is a key factor in obesity-related metabolic dysfunction.
  • Inflammation patterns vary across different energy balance states (obesity, overfeeding, weight loss).
  • Conditions like type 2 diabetes and polycystic ovarian syndrome are associated with altered adipose tissue inflammation.

Conclusions:

  • Adipose tissue inflammation is central to the development of obesity complications.
  • Understanding adipose tissue inflammation is crucial for managing metabolic disorders.
  • Further research on therapeutic strategies targeting adipose tissue inflammation is warranted.